Regeneron Pharmaceuticals, Inc.

REGN

$838.63

-0.57%

2026-09-04 09:50:39 EDT-$4.84

Healthcare

Biotechnology

NASDAQ

Active Trading

Regeneron Pharmaceuticals, Inc. is a global biopharmaceutical enterprise focused on discovering, inventing, developing, manufacturing, and bringing to market medical treatments for a ...

Historical Employee Count of REGN

Current

15,410

Change

+2.01%

Minimum

10,368

Maximum

15,410

Recent Filings

Report Date	Employees	Form Type	Filing Date	SEC Filing
Dec 31, 2025	15,410	10-K	Feb 4, 2026	View
Dec 31, 2024	15,106	10-K	Feb 5, 2025	View
Dec 31, 2023	13,450	10-K	Feb 5, 2024	View
Dec 31, 2022	11,851	10-K	Feb 6, 2023	View
Dec 31, 2021	10,368	10-K	Feb 7, 2022	View

Supply Chain of REGN

Upstream / Downstream / Proxies

Upstream

Fujifilm Diosynth Biotechnologies (Fujifilm Holdings)TYO:4901Novo Nordisk (Catalent Indiana facility, Bloomington, IN)NYSE:NVO Regeneron Internal Manufacturing (IOPS)NASDAQ:REGNSartorius AGXETRA:SRT3Thermo Fisher Scientific Inc.NYSE:TMO Danaher Corporation (Cytiva)NYSE:DHRMerck KGaAXETRA:MRK

Downstream

SanofiEURONEXT:SANBayer AGXETRA:BAYNCencora, Inc. (formerly AmerisourceBergen)NYSE:COR Cardinal Health, Inc.NYSE:CAH McKesson CorporationNYSE:MCK CVS Specialty Pharmacy (CVS Health)NYSE:CVS Accredo Health Group (The Cigna Group)NYSE:CI Optum Specialty Pharmacy (UnitedHealth Group)NYSE:UNHSanten Pharmaceutical Co., Ltd.TYO:4536Teva Pharmaceutical Industries Ltd.NYSE:TEVA

Proxies

SanofiEURONEXT:SANBayer AGXETRA:BAYNBiogen Inc.NASDAQ:BIIB Vertex Pharmaceuticals Inc.NASDAQ:VRTX

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer